Cell line · CVCL_4833
CWR-R1
Cancer cell line, Homo sapiens. Prostate carcinoma. 13 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. CWR-R1. Cell lines, record CVCL_4833. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_4833
On this page
Cell line
As Cellosaurus gives it.
- Name
- CWR-R1
- Accession
- CVCL_4833
- RRID
- RRID:CVCL_4833
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- Adult
- Category
- Cancer cell line
- Diseases
- Prostate carcinoma (NCIt C4863)
- Derived from
- Prostate (in situ)
- Parent
- CWR22 (CVCL_3967)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers13
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| MECOM Function Is Critical for AR-Driven Treatment-Resistant Prostate Cancer. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Encapsulation and Delivery of the Kinase Inhibitor PIK-75 by Organic Core High-Density Lipoprotein-Like Nanoparticles Targeting Scavenger Receptor Class B Type 1. | ACS Appl Mater Interfaces | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Targeting the cancer cells and cancer-associated fibroblasts with next-generation FGFR inhibitors in prostate cancer co-culture models. | Cancer Med | 2024 | Its Methods give the RRID and name the line | PubMed | |
| ERBB3 Overexpression is Enriched in Diverse Patient Populations with Castration-sensitive Prostate Cancer and is Associated with a Unique AR Activity Signature. | Clin Cancer Res | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist-Treated Prostate Cancers. | Mol Cancer Res | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Serum-free complete medium, an alternative medium to mimic androgen deprivation in human prostate cancer cell line models. | Prostate | 2018 | Cellosaurus cites it | PubMed | |
| Characterization of fibroblast-free CWR-R1ca castration-recurrent prostate cancer cell line. | Prostate | 2016 | Cellosaurus cites it | PubMed | |
| Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer. | Oncotarget | 2016 | Cellosaurus cites it | PubMed | |
| Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines. | Cancer Res | 2013 | Cellosaurus cites it | PubMed | |
| Models for prostate cancer. Molecular characterization and critical appraisal of human prostate carcinoma cell lines. | 2004 | Cellosaurus cites it | Cellosaurus |
1 to 10 of 13
See all 13 papersRelatives5
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | CWR22 | CVCL_3967 | Cell lines | |
| Derived from it | CWR-R1-AD1 | CVCL_ZC60 | Cell lines | |
| Derived from it | CWR-R1-EnzR | CVCL_RA55 | Cell lines | |
| Derived from it | CWR-R1ca | CVCL_LI36 | Cell lines | |
| Derived from it | CWR-R1fb | CVCL_LI37 | Cell lines |
Cell banks2
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ABM | T8263 | ABM | |
| Kerafast | ENC005 | Discontinued | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_4833
GET https://conductscience.org/api/cell-lines/v1/CVCL_4833/problems